生物材料在再生醫學、長壽醫學和仿生醫學領域的未來：技術與市場（2027-2047）

概要

未來20年，具備健康活到120歲潛能的人口數可望增加。這主要歸功於未來生物材料的出現，這些材料將使客製化培養器官的製造成為可能，用於移植和其他應用。這份259頁的報告從商業性觀點出發，詳細說明了增值材料供應商、醫療設備製造商、系統整合商和醫療保健專業人員在該領域的商機。報告重點關注再生醫學、長壽醫學和仿生醫學等相互關聯的領域所需的下一代材料和設備。例如，說明了隨著再生醫學市場規模擴大至4000億美元，新型生物材料將如何發揮關鍵作用。

除了自然和醫學領域之外，其他領域的進步也帶來了巨大的可能性。

有些陸生動物的壽命可達300年，為延長人類壽命提供了寶貴的啟示。同樣，有些水生動物的壽命可達15,000年，並擁有再生許多主要器官的能力，為我們提供了重要的經驗。雖然生物材料已應用於一些治療方法，但工程化活體材料（ELM）有望顯著拓展其應用潛力。預計到2047年，用於移植的ELM培養器官市場規模將達到100億美元。

基準測試和最新進展

本報告說明了截至2026年的最新研究成果所帶來的商業機會。這一點至關重要，因為在這個快速發展的領域，過時的資訊可能會產生誤導。例如，羅馬萬神殿之所以能夠屹立近2000年，正是得益於其所使用的自癒混凝土。目前，人們對利用具有自癒能力的非生物聚合物生物材料來修復人體組織的興趣日益濃厚。

超越人類能力的潛力

新型無機和有機生物材料甚至可能使人類獲得超越常人的能力——所謂的「超人能力」。例如，能夠消除牙痛的牙科植體就是一個例子。未來，是否有可能植入超越人類的聽覺和視覺能力？人類已經佩戴自驅動的工業外骨骼來應對繁重的體力勞動。如果真是如此，那麼我們進入一個超高性能義肢可以作為自訂選項的時代也就不足為奇了。本報告分析了未來生物材料可能帶來的這些以及其他許多可能性。

未來生物材料

在本報告中，生物材料被定義為任何旨在與生物系統安全相互作用，用於治療或診斷的天然或合成物質。治療用途包括組織治療、修復和替代。生物材料本質上是面向硬體的材料，與劑量導向的藥物有所不同。然而，生醫材料可以植入或局部應用，以局部的方式將藥物輸送到目標。

目錄

第1章：摘要整理與結論

• 本報告的目的、研究方法和背景
• 對再生醫學、長壽醫學和仿生人的說明。
• 12項主要結論
• 再生醫學、長壽醫學和仿生人的SWOT分析
• 從大自然中學到的長壽秘訣
• 在實現擁有超人能力的仿生人方面取得進展
• 資訊圖表：生物材料範例、使用這些生物材料的設備以及製造和處理方面面臨的挑戰。
• 非生物自癒生物材料和工程活性材料（ELMs）的重要性
• 十項與生物材料和實行技術。
• 藍圖
• 市場預測：圖表和說明
  • 全球再生醫學市場規模
  • 用於醫療保健和其他應用的 ELM 培養器官植入：謹慎的情境預測
  • 用於醫療保健和其他應用的 ELM 培養器官植入：顛覆性情境預測
  • 通用自修復材料市場：ELM與整體市場的比較
  • 醫療保健自癒材料市場：患者向け與建築/設備向け（建築/設施-向け）應用的比較。
  • 四個區域醫療保健領域 ELM 市場佔有率
  • 醫療保健產業ELM製造商的數量
  • 用於醫療保健的自修復材料技術的成熟曲線

第2章：向大自然學習－自我修復、再生與長壽

• 我們能從大自然學到什麼？許多物種擁有比人類更強大的能力，尤其是水生生物。
• 其他展現卓越自癒和再生能力的例子
• 如果機制被理解：分化、幹細胞介導的調控、形態調控
• 如果機制尚未明確
• 為什麼人類的再生能力這麼差？ ：一個近在咫尺卻又遙不可及的現實。
• 從大自然中學到的長壽秘訣

第3章：再生醫學、長壽醫學和仿生人

• 再生醫學、長壽、仿生人：資訊圖表 SWOT 分析
  • 重疊區域
  • 再生醫學、長壽醫學和仿生人的SWOT分析
• 再生醫學
  • 概述
  • 主要再生醫學技術
  • 再生醫學中的倫理和監管問題
  • 2025年及以後的發展實例
• 長壽醫學
  • 概述
  • 長壽醫學和再生醫學的重疊領域
  • 長壽醫學中的倫理與監管挑戰
  • 2025年及以後的發展實例
• 仿生人
  • 2027 年至 2047 年間將成為現實的概念，以及隨之而來的倫理和監管挑戰。
  • 在實現擁有超人能力的仿生人方面取得進展
  • 腦機介面和其他電子學

第4章：未來生物材料助力更健康、更長壽的生活：整體趨勢

• 概述
  • 定義和範圍
  • 資訊圖表：生物材料範例、使用這些生物材料的設備以及製造和處理方面面臨的挑戰。
  • 用於癌症免疫療法和幹細胞組織工程的新興生物材料
  • 計畫中的離子電子學型腦機介面、神經形態計算和醫療感測器。
  • 用於仿生人的下一代致動器
• 提高現有及未來生物材料的功能性和有效性
  • 新興生物材料的種類與功能：凝膠、奈米複合材料、裝置等。
  • 對醫用離子凝膠進行 SWOT 分析，圓餅圖顯示研究中最有前途的材料，以及 2026 年的研究進展。
  • 2026 年的先進醫用水凝膠：皮膚/肌肉模擬、再生等。
• 生物材料領域的其他重要進展
• 參與下一代生物材料研發的54家公司

第5章 用於長壽醫學和再生醫學的非生物自修復材料

• 展示了趨勢、資訊圖表和案例研究。
• 定義、機制、新興應用、未來機遇
• 市場促進因素與選擇
  • 向自修復智慧生物材料過渡
  • 使用壽命長、可靠性高、無需維護，並向更年輕、更有活力的使用壽命過渡。
  • 材料與製造商分析：最新圖表
  • 仿生技術－仍有發展空間
  • 我們對自然癒合機制的理解不斷加深，將加速未來自癒合材料的研發。
  • 超越仿生技術
• 34 個結論，4 個新資訊圖，以及 7 個 SWOT 分析。
• 2025年及以後自癒材料研究案例分析

第6章 用於再生醫學和老年醫學的工程活性材料（ELM）

• 工程化生命材料的定義、主要子類別及SWOT分析
• 基於仿生技術的ELM設計方法
• 創建和實施 ELM 的四個階段
• 工程生活通訊中整合的設計特性
• ELM 的目的與應用
• ELM在科學和醫療保健中的作用
• 主要結論：新興的ELM市場，新的資訊圖表和餅圖分析
• 主要結論：ELM 設計、材料、製造和新型資訊圖、SWOT 分析和圓餅圖分析。
• ELM基準測試和設計進度分析
  • 基準測試
  • 適應性和進化性生物材料作為整合系統
  • 透過人工智慧設計創建的新ELM選項
  • 生物工程ELM和真菌ELM
  • 控釋藥物傳輸型ELM
  • 利用生物載體基質和生物水凝膠實現自生長、機械可調的ELM
  • ELM 是一種可程式設計材料，可直接從活細胞中生長。
  • 製備 ELM 聚合物基質以控制微生物黏附、生長、空間排列和表現型。
• ELM在特定療法中的進展
  • ELM在生物修復和生物治療的應用
  • 用於癌症免疫療法的ELM
  • 免疫工程
  • 感染性角膜炎的治療
  • ELM治療發炎性腸道疾病
  • ELM 是一種益生菌生物材料，可以解決陰道環境失衡和其他症狀。
  • 手術部位感染

Summary

The next twenty years may see many people born with the prospect of living healthily to 120 years. That may be largely due to future biomaterials enabling such things as custom-grown replacement organs. The 259-page, commercially-oriented report, “Biomaterials for Future Regenerative, Longevity and Bionic Medicine: Technology, Markets 2027-2047”, details your opportunities in all this. That is whether you are an added-value materials supplier, device manufacturer, integrator or medical practitioner. Primary focus is the next materials and devices for the overlapping topics of regenerative and longevity medicine and bionic man and woman. For instance, see how new biomaterials will be key to the regenerative medicine market as it rises to $400 billion.

Nature and non-medical advances present huge possibilities

Some land animals live for 300 years, inspiring us to do better, and we can also learn from how some aquatic animals live for 15,000 years and regrow most organs. Living material is used in some therapy but Engineered Living Materials ELM will now take that to a new level. One later aspect – those ELM grown organs for implanting – is predicted to rise to the $10 billion level by 2047.

Benchmarking and latest advances

Importantly, the report explains your opportunities from the flood of latest research advances through 2026 because old news is misleading in this fast-moving topic. For example, the Roman Pantheon has been in use for nearly 2000 years thanks to self-healing concrete. Now attention has turned to renovation of human body with inanimate, self-healing, polymeric biomaterials.

Exceeding human capabilities?

Both inanimate and animate new biomaterials will even give us the option of superpowers beyond those of a regular human being. We already see a hint of this in dental implants incapable of toothache: shall we implant superhuman hearing or sight? Humans clip on a self-powered industrial exoskeleton to cope with heavy work so is it time for super-prosthetics as a custom-option? This report analyses these and many other options with future biomaterials.

Future biomaterials

For the purposes of this report, a biomaterial is any natural or synthetic substance engineered to interact safely with biological systems for a medical purpose, either therapeutic (treating, repairing, or replacing tissue) or diagnostic. A biomaterial (hardware oriented) is not a pharmaceutical (dose oriented), but it may be implanted or applied to deliver a pharmaceutical in a targetted and controlled manner.

Comprehensive, balanced report with much 2026 research

The Executive Summary and Conclusions (56 pages) is sufficient in itself, with the basics, six new pie charts (including materials favoured), ten of the SWOT appraisals, 12 key conclusions, roadmaps, and all 13 forecasts with tables, graphs, explanations.

Chapter 2. Learning from Nature – Self-healing, Regeneration and Longevity (13 pages) shows how understanding and copying other living things promises enormous advances in regeneration and longevity, including regrowing more parts of the body, copying mechanisms in some animals.

Chapter 3. Regenerative Medicine, Longevity, Bionic Man and Woman (15 pages) clarifies definitions, objectives, technologies, ethical and regulatory issues, including explanation of the many advances in 2025-6.

Learn the emerging materials, devices, applications

Chapter 4. Future Biomaterials Supporting Better and Longer Life: General Situation (41 pages) explains latest 2025-6 research and industry approaches and challenges to explain what will be new in the 2027-2047 timeframe. One is brain-computer interfaces with the new soft iontronics with its innovative new ionogels now succeeding in many other medical advances, including where the familiar medical hydrogels are inadequate. However, there are also radically improved hydrogels discussed that will achieve success. See definitions, scope and companies involved in new biomaterials with a need for many more. Self-healing inanimate materials and Engineered Living Materials are considered to be particularly impactful additions through 2027-2047, so they have their own separate chapters that follow.

Chapter 5. Inanimate Self-healing Materials for Longevity and Regenerative Medicine (62 pages) has many SWOT reports and infograms, 34 conclusions and much analysis of the research advances 2025-6. It finds that the trends to long life, reliability, fit-and-forget and rejuvenation are creating many medical opportunities. For example, being perfected are self-healing, bio-interfaced electronics, prosthetics, soft robotics for surgery, safety footwear, embedded sensors and embedded drug delivery systems. Self-healing biobased and polymer systems are a strong focus.

Chapter 6. Engineered Living Materials ELM for Regenerative and Longevity Medicine closes the report with a full 57 pages for here is the possibility of custom growth of your replacement kidney, heart, liver and so much more and much research is succeeding with many discussed specifics. They include dramatically better cancer immunotherapy, immune engineering, and tackling infectious keratitis, inflammatory bowel disease and surgical site infections far more effectively. Learn the basics, challenges and favored materials for ELM living materials and scaffolds. How do probiotics and exosomes fit in here? 2026 advances, listed conclusions, SOFT appraisals, benchmarking and infograms make it all clear.

The report, “Biomaterials for Future Regenerative, Longevity and Bionic Medicine: Technology, Markets 2027-2047” is your essential guide to creating a one-billion-dollar business in this rapidly emerging market.

Table of Contents

1. Executive Summary and Conclusions

• 1.1 Purpose, methodology and background of this report
• 1.2 Regenerative medicine, longevity, bionic man and woman explained
• 1.3 Twelve key conclusions
• 1.4 SWOT appraisal of regenerative medicine, longevity medicine and bionic man and woman
• 1.5 Longevity lessons from nature
• 1.6 Progress towards bionic man and woman with super-powers
• 1.7 Infograms: Examples of biomaterials, devices using them, manufacturing and handling issues
• 1.8 Importance of inanimate self-healing biomaterials and Engineered Living Materials 2027-2047
• 1.9 Ten SWOT appraisals of enabling biomaterials and technologies with materials analyses
• 1.10 Roadmaps 2027-2047
• 1.11 Market forecasts as graphs, tables, explanation 2027-2047
  • 1.11.1 Regenerative medicine global market size $ billion 2027-2047
  • 1.11.2 Healthcare ELM grown organ implants vs other $ billion cautious forecast 2027-2047
  • 1.11.3 Healthcare ELM grown organ implants vs other $ billion topside forecast 2027-2047
  • 1.11.4 Self-healing materials market for all applications: ELM vs total 2027-2047
  • 1.11.5 Self-healing materials for healthcare value market: patient vs buildings and equipment $ billion 2027-2047
  • 1.11.6 Percentage share of healthcare ELM value market by four regions 2027-2047
  • 1.11.7 Number of healthcare ELM manufacturers 2027-2047
  • 1.11.8 Maturity curves of self-healing material technologies in healthcare 2027, 2037,

2. Learning from nature – self-healing, regeneration and longevity

• 2.1 What can we learn from nature? Many species better than us, particularly aquatic
• 2.2 Other examples of superior self-healing and regrowth
• 2.3 Sometimes we know how it is done: differentiation, stem cell mediation, morphallaxis
• 2.4 Sometimes we do not know how it is done
• 2.5 Why are humans poor at regenerating? So near and yet so far
• 2.6 Longevity lessons from nature

3. Regenerative medicine, longevity, bionic man and woman

• 3.1 Regenerative medicine, longevity, bionic man and woman: infogram and SWOT
  • 3.1.1 Overlapping topics
  • 3.1.2 SWOT appraisal of regenerative medicine, longevity medicine and bionic man and woman
• 3.2 Regenerative medicine
  • 3.2.1 Overview
  • 3.2.2 Key Regenerative Medicine Technologies
  • 3.2.3 Ethical and regulatory issues of regenerative medicine
  • 3.2.4 Examples of advances in 2025 through
• 3.3 Longevity medicine
  • 3.3.1 Overview
  • 3.3.2 Longevity medicine overlaps regenerative
  • 3.3.3 Ethical and regulatory issues of longevity medicine
  • 3.3.4 Examples of advances 2025 through
• 3.4 Bionic man and woman
  • 3.4.1 Fantasies becoming real with ethical and regulatory issues 2027-2047
  • 3.4.2 Progress towards bionic man and woman with super-powers
  • 3.4.3 Brain computer interfaces and other iontronics

4. Future biomaterials supporting better and longer life: general situation

• 4.1 Overview
  • 4.1.1 Definitions and scope
  • 4.1.2 Infogram: Examples of biomaterials, devices using them, manufacturing and handling issues
  • 4.1.3 Emerging biomaterials for cancer immunotherapy and stem cell tissue engineering
  • 4.1.4 Planned iontronic brain-computer interfaces, neuromorphic computing and medical sensors
  • 4.1.5 Next-generation actuators for bionic man and woman
• 4.2 Increasing the functionality and effectiveness of current and future biomaterials
  • 4.2.1 Emerging biomaterial types and capabilities: including gels, nanocomposites, devices
  • 4.2.2 SWOT appraisal of medical ionogels, pie charts of the most successful materials in research, 2026 research advances
  • 4.2.3 Advanced medical hydrogels in 2026: skin and muscle-mimicking, regenerative, other
• 4.3 Other important biomaterial advances through
• 4.4 54 of the companies involved in next-generation biomaterials

5. Inanimate self-healing materials for longevity and regenerative medicine

• 5.1 Introduction with trends, infogram and medical examples through
• 5.2 Definitions, mechanisms, emerging applications, future opportunities
• 5.3 Market drivers and options
  • 5.3.1 Trend to self-healing smart biomaterials
  • 5.3.2 Trend to long life, reliability, fit-and-forget, rejuvenation
  • 5.3.3 Materials and manufacturer analysis: new charts
  • 5.3.4 Biomimetics – much further to go
  • 5.3.5 Advances in understanding natural healing leverage future self-healing materials
  • 5.3.6 Beyond biomimetics
• 5.4 34 conclusions with 4 new infograms and 7 SWOT appraisals
  • 5.4.1 Addressable markets: 10 general conclusions, infograms and SWOT appraisals
  • 5.4.2 Emerging technologies and capabilities: 24 key conclusions, infograms, SWOT appraisals
• 5.5 Analysed examples of research on self-healing materials in 2025 through

6. Engineered Living Materials ELM for regenerative and longevity medicine

• 6.1 Introduction
• 6.2 Engineering Living Materials definition, simple subsets, SWOT appraisals
• 6.3 Biomimetic ELM design approaches
• 6.4 Four stages of ELM creation and deployment
• 6.5 Features designed into engineered living materials
• 6.6 ELM objectives and applications 2027-2047
• 6.7 ELM place in science and healthcare
• 6.8 Primary conclusions: emerging ELM markets with new infograms and pie chart analysis
• 6.9 Primary conclusions: ELM design, materials, manufacturing with new infograms, SWOT and pie chart analysis
• 6.10 Analysis of ELM benchmarking and design advances through
  • 6.10.1 Benchmarking
  • 6.10.2 Adaptive and evolving living materials as integrated systems
  • 6.10.3 AI design created new ELM options in
  • 6.10.4 Bioengineered and fungal ELM
  • 6.10.5 Controlled drug delivery ELM
  • 6.10.6 Living carrier matrices, living hydrogels enable self-growing and mechanically tunable ELM
  • 6.10.7 Programmable materials grown directly from living cells as ELM
  • 6.10.8 Tuning ELM polymer matrices to direct microbial adhesion, growth, spatial organization, phenotype
• 6.11 ELM advances for specific therapies in
  • 6.11.1 Bioremediation and biotherapeutics ELM
  • 6.11.2 Cancer immunotherapy ELM
  • 6.11.3 Immune engineering
  • 6.11.4 Infectious keratitis therapy
  • 6.11.5 Inflammatory bowel disease ELM
  • 6.11.6 Probiotic Living Materials ELM for vaginal imbalances and other conditions
  • 6.11.7 Surgical site infections